Evidence-Based Medicine Guidelines
Transdermal fentanyl for cancer pain
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transdermal Fentanyl for Cancer Pain." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain.
Transdermal fentanyl for cancer pain. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain. Accessed May 12, 2025.
Transdermal fentanyl for cancer pain. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain
Transdermal Fentanyl for Cancer Pain [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transdermal fentanyl for cancer pain
ID - 458185
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458185/all/Transdermal_fentanyl_for_cancer_pain
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
